Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.
暂无分享,去创建一个
P. L. Bergsagel | W. Kuehl | I. Kirsch | G. Dewald | Y. Qi | A. Roschke | M. Martelli | Y. Shou | A. Gabrea | L. Brents | Y. Shou | Ana Gabrea | Ying Qi
[1] R. Bataille,et al. High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization , 1999, Genes, chromosomes & cancer.
[2] P. L. Bergsagel,et al. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. , 1999, Molecular cell.
[3] B. Barlogie,et al. Identification of New Nonrandom Translocations in Multiple Myeloma With Multicolor Spectral Karyotyping , 1998 .
[4] J. Westwick,et al. Chemokines and T lymphocytes: more than an attraction. , 1998, Immunity.
[5] E. Schröck,et al. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. , 1998, Blood.
[6] U. Klein,et al. Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[7] F. Mills,et al. Enhancer Complexes Located Downstream of Both Human Immunoglobulin Cα Genes , 1997, The Journal of experimental medicine.
[8] M. Taniwaki,et al. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. , 1997, Blood.
[9] E. Schröck,et al. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3 , 1997, Nature Genetics.
[10] J. Cigudosa,et al. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations , 1997, Genes, chromosomes & cancer.
[11] P. L. Bergsagel,et al. IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc. , 1997, Current topics in microbiology and immunology.
[12] P. L. Bergsagel,et al. Dysregulation of c-myc in multiple myeloma. , 1997, Current topics in microbiology and immunology.
[13] D. Zimonjic,et al. Molecular cytogenetic characterization of cancer cell alterations. , 1997, Cancer genetics and cytogenetics.
[14] P. L. Bergsagel,et al. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[15] W. Kuehl,et al. Selective expression of one c-myc allele in two human myeloma cell lines. , 1996, Cancer research.
[16] B. Barlogie,et al. Cytogenetic findings in 200 patients with multiple myeloma. , 1995, Cancer genetics and cytogenetics.
[17] J. Mary,et al. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. , 1995, Blood.
[18] M. Potter,et al. Differences in the molecular structure of c-myc-activating recombinations in murine plasmacytomas and precursor cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Jourdan,et al. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. , 1994, Blood.
[20] N. Carter,et al. A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q , 1994, Nature Genetics.
[21] Ilan R. Kirsch,et al. The Causes and Consequences of Chromosomal Aberrations , 1992 .
[22] M. Pettersson,et al. Expression of myc‐family genes in established human multiple myeloma cell lines: L‐myc but not c‐myc gene expression in the U‐266 myeloma cell line , 1992, International journal of cancer.
[23] S. Korsmeyer,et al. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. , 1992, Annual review of immunology.
[24] H. Asaoku,et al. Increased expression of the c‐myc gene may be related to the aggressive transformation of human myeloma cells , 1991, British journal of haematology.
[25] T. McDonnell,et al. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.
[26] R. Benner,et al. Amplification of the c-myc and the pvt-like region in human multiple myeloma. , 1990, Oncogene.
[27] M. Taniwaki,et al. Amylase-producing plasmacytoma cell lines, AD3 and FR4, with der(14)t(8;14) and dic(8)t(1;8) established from ascites. , 1990, Leukemia.
[28] O. Olopade,et al. Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11) , 1990, Genes, chromosomes & cancer.
[29] P. Sherrington,et al. A new human plasma cell line, Karpas 620, with translocations involving chromosomes 1, 11 and 14 , 1990, British journal of haematology.
[30] J. S. Lee,et al. Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Boccadoro,et al. The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation. , 1989, Blood.
[32] T. Grogan,et al. Myelomonocytic myeloma cell line (LB 84-1). , 1989, Blood.
[33] J. Gerdes,et al. Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67. , 1988 .
[34] W. O'Fallon,et al. Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma. , 1988, Blood.
[35] A. Gazdar,et al. Complex translocation disrupts c-myc regulation in a human plasma cell myeloma , 1988, Molecular and cellular biology.
[36] J. Battey,et al. Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing , 1988, Molecular and cellular biology.
[37] J. Battey,et al. Human small-cell lung cancers show amplification and expression of the N-myc gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[38] S. Korsmeyer,et al. Translocations that highlight chromosomal regions of differentiated activity. , 1985, Cancer genetics and cytogenetics.
[39] S. Tarui,et al. Two distinct human myeloma cell lines originating from one patient with myeloma , 1985, International journal of cancer.
[40] R. Kyle,et al. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. , 1985, Blood.